Chugai Pharmaceutical Co., Ltd. (4519)

4,160.0
-16.0(-0.38%)
  • Volume:
    2,673,700
  • Bid/Ask:
    4,158.0/4,161.0
  • Day's Range:
    4,132.0 - 4,210.0
  • Type:Equity
  • Market:Japan
  • ISIN:JP3519400000

4519 Overview

Prev. Close
4,176
Day's Range
4,132-4,210
Revenue
809.06B
Open
4,175
52 wk Range
3,898-6,435
EPS
140.16
Volume
2,673,700
Market Cap
6.84T
Dividend (Yield)
60.00
(1.44%)
Average Volume (3m)
2,343,651
P/E Ratio
29.80
Beta
0.94
1-Year Change
-20.01%
Shares Outstanding
1,644,208,720
Next Earnings Date
Oct. 22, 2021
What is your sentiment on Chugai Pharmaceutical Co., Ltd.?
or
Market is currently closed. Voting is open during market hours.

Chugai Pharmaceutical Co., Ltd. News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyBuySellNeutral
Technical IndicatorsStrong BuyStrong BuyNeutralStrong SellSell
SummaryStrong BuyStrong BuyNeutralStrong SellNeutral

Chugai Pharmaceutical Co., Ltd. Company Profile

Chugai Pharmaceutical Co., Ltd. Company Profile

Industry
Major Drugs
Employees
7555
Market
Japan

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.